PENTOTHAL Side Effects

6188744-5 | Anaphylactic Reaction, Bradycardia
on May 11, 2009 Male patient from UNITED STATES , 50 years of age, weighting 183.0 lb, was diagnosed with anaesthesia and was treated with Pentothal (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, bradycardia. Pentothal dosage: 250mg Once Iv.

6035315-7 | Anaphylactic Shock, Erythema
Patient was taking Pentothal (View Usage). Patient had the following side effects: anaphylactic shock, erythema on Dec 10, 2008 from Additional patient health information: Female patient , 60 years of age, was diagnosed with anaesthesia, induction of anaesthesia and. Pentothal dosage: 300 Mg, Intravenous. During the same period patient was treated with PROPOFOL (4 Mg/kg, Intravenous Drip) (View Propofol Review and Propofol Label ), (SUXAMETHONIUM) (100 Mg, Intravenous Bolus) (View (suxamethonium) Review and (suxamethonium) Label ), ULTIVA (REMIFENTANIL HYDROCHLORIDE FOR INJECTION (55) (REMIFENTANIL) (View Ultiva (remifentanil Hydrochloride For Injection (55) (remifentanil) Review and Ultiva (remifentanil Hydrochloride For Injection (55) (remifentanil) Label ), ANAESTHESIA (ANAESTHESIA) (View Anaesthesia (anaesthesia) Review and Anaesthesia (anaesthesia) Label ).

6010910-X | Haematocrit Decreased, Loss Of Consciousness, Movement Disorder, Speech Disorder
Adverse event was reported on Dec 03, 2008 by a Female patient taking Pentothal (View Usage) (Dosage: ) . Location: UNITED STATES , 39 years of age, After Pentothal was administered, patient had the following side effects: haematocrit decreased, loss of consciousness, movement disorder (What is movement disorder?), speech disorder. During the same period patient was treated with FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), VERSED (View Versed Review and Versed Label ), ANTI NAUSEA (ANTI NAUSEA /02089301?) (View Anti Nausea (anti-nausea /02089301?) Review and Anti Nausea (anti-nausea /02089301?) Label ). Patient was hospitalized.

5944527-X | Anaesthetic Complication, Caesarean Section, Procedural Pain, Unwanted Awareness During Anaesthesia
on Oct 26, 2008 Female patient from AUSTRALIA , 34 years of age, weighting 198.4 lb, was diagnosed with induction of anaesthesia, maintenance of anaesthesia and was treated with Pentothal (View Usage). Patient experienced the following unwanted or unexpected effects: anaesthetic complication, caesarean section, procedural pain, unwanted awareness during anaesthesia. Pentothal dosage: 3.3 Mg/kg,. During the same period patient was treated with REMIFENTANIL (REMIFENTANIL) (50 Mcg,) (View Remifentanil (remifentanil) Review and Remifentanil (remifentanil) Label ), SUXAMETHONIUM (SUXAMETHONIUM) (View Suxamethonium (suxamethonium) Review and Suxamethonium (suxamethonium) Label ), ATRACURIUM BESYLATE (View Atracurium Besylate Review and Atracurium Besylate Label ), 0.2% ISOFLURANE (ISOFLURANE) (View 0.2% Isoflurane (isoflurane) Review and 0.2% Isoflurane (isoflurane) Label ), 50% NITROUS OXIDE (NITROUS OXIDE) (View 50% Nitrous Oxide (nitrous Oxide) Review and 50% Nitrous Oxide (nitrous Oxide) Label ), MORPHINE (View Morphine Review and Morphine Label ).


5939440-8 | Anaphylactic Reaction, Blood Pressure Decreased, Bronchial Obstruction, Oxygen Saturation Decreased
on Oct 07, 2008 Female patient from NORWAY , 35 years of age, was treated with Pentothal (View Usage). Patient had the following side effects: anaphylactic reaction, blood pressure decreased, bronchial obstruction, oxygen saturation decreased. Pentothal dosage: . During the same period patient was treated with SUXAMETHONIUM (View Suxamethonium Review and Suxamethonium Label ).

5933683-5 | Condition Aggravated, Creutzfeldt-jakob Disease, Electroencephalogram Abnormal, False Negative Laboratory Result
Patient was taking Pentothal (View Usage). After Pentothal was administered, patient had the following side effects: condition aggravated, creutzfeldt-jakob disease (What is creutzfeldt-jakob disease?), electroencephalogram abnormal, false negative laboratory result on Oct 13, 2008 from BELGIUM Additional patient health information: Female patient , 47 years of age, . Pentothal dosage: . During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), LEVETIRACETAM (View Levetiracetam Review and Levetiracetam Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), PREGABALIN (PREGABALIN) (View Pregabalin (pregabalin) Review and Pregabalin (pregabalin) Label ).

5883256-8 | Heart Rate Increased, Unwanted Awareness During Anaesthesia
Adverse event was reported on Sep 02, 2008 by a Male patient taking Pentothal (View Usage) (Dosage: 3.6 Mcg/kg Intravenous; 1mg/kg, Once, Intravenous) was diagnosed with induction of anaesthesia, endotracheal intubation, maintenance of anaesthesia and. Location: NETHERLANDS , child 8 years of age, weighting 77.16 lb, Patient experienced the following unwanted or unexpected effects: heart rate increased, unwanted awareness during anaesthesia. During the same period patient was treated with FENTANYL 100 (3 Mcg/kg, Intravenous; 1.5 Mcg/kg, Once, Intravenous) (View Fentanyl-100 Review and Fentanyl-100 Label ), ROCURONIUM BROMIDE (0.6 Mg/kg, Intravenous; 10 Mg, Intravenous) (View Rocuronium Bromide Review and Rocuronium Bromide Label ), 1.5% ISOFLURANE (ISOFLURANE) (Inhalation) (View 1.5% Isoflurane (isoflurane) Review and 1.5% Isoflurane (isoflurane) Label ), EMLA CREAM (EMLA /00675501/) (View Emla Cream (emla /00675501/) Review and Emla Cream (emla /00675501/) Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ).

5874843-1 | Bronchospasm, Hypersensitivity, Oxygen Saturation Decreased, Tachycardia
on Aug 26, 2008 Male patient from NORWAY , 41 years of age, weighting 297.6 lb, was diagnosed with induction of anaesthesia, endotracheal intubation and was treated with Pentothal (View Usage). Patient had the following side effects: bronchospasm, hypersensitivity, oxygen saturation decreased, tachycardia. Pentothal dosage: 500 Mg, 1 In 1 Dose, Intravenous. During the same period patient was treated with SUXAMETHONIUM (SUXAMETHONIUM) (150 Mg, 1 In 1 Dose, Intravenous) (View Suxamethonium (suxamethonium) Review and Suxamethonium (suxamethonium) Label ), FENTANYL 100 (0.2 Mg, 1 In 1 Dose, Intravenous) (View Fentanyl-100 Review and Fentanyl-100 Label ).

5859106-2 | Bronchospasm, Flushing, Oxygen Saturation Decreased, Tachycardia, Urticaria
on Aug 13, 2008 Male patient from NORWAY , 41 years of age, weighting 297.6 lb, was diagnosed with induction of anaesthesia, endotracheal intubation and was treated with Pentothal (View Usage). After Pentothal was administered, patient had the following side effects: bronchospasm, flushing, oxygen saturation decreased, tachycardia, urticaria. Pentothal dosage: 500 Mg, 1 In 1 Dose, Intravenous. During the same period patient was treated with SUXAMETHONIUM (SUXAMETHONIUM) (150 Mg, 1 In 1 Dose, Intravenous) (View Suxamethonium (suxamethonium) Review and Suxamethonium (suxamethonium) Label ), FENTANYL 100 (0.2 Mg, 1 In 1 Dose, Intravenous) (View Fentanyl-100 Review and Fentanyl-100 Label ).

5856902-2 | Anaesthetic Complication, Dysgeusia
Patient was taking Pentothal (View Usage). Patient experienced the following unwanted or unexpected effects: anaesthetic complication, dysgeusia on Aug 21, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 198.2 lb, . Pentothal dosage: 325 Mg Once Iv.

5779712-3 | Bronchospasm, Hypotension, Hypoxia, Tachycardia
Adverse event was reported on Jun 02, 2008 by a Male patient taking Pentothal (View Usage) (Dosage: 350 Mg, 1 In 1 D, Parenteral) was diagnosed with endotracheal intubation, induction of anaesthesia, pain (What is pain?) and. Location: NORWAY , 88 years of age, Patient had the following side effects: bronchospasm, hypotension, hypoxia, tachycardia. During the same period patient was treated with NIMBEX(CISATRACURIM BESILATE) (6 Mg, 1 In 1 D, Parenteral) (View Nimbex(cisatracurim Besilate) Review and Nimbex(cisatracurim Besilate) Label ), CURACIT (SUXAMETHONIUM CHLORIDE) (100 Mg, 1 In 1d, Intravenous (not Otherwise Specified)) (View Curacit (suxamethonium Chloride) Review and Curacit (suxamethonium Chloride) Label ), FENTANYL (.1 Mg And .15 Mg, Parenteral) (View Fentanyl Review and Fentanyl Label ), SEVOFLURAN BAXTER (SEVOFLURANE) (View Sevofluran Baxter (sevoflurane) Review and Sevofluran Baxter (sevoflurane) Label ).

5723589-9 | Hyperkalaemia, Hypokalaemia, Rebound Effect
on Apr 15, 2008 Male patient from CANADA , 32 years of age, was diagnosed with intracranial pressure increased and was treated with Pentothal (View Usage). After Pentothal was administered, patient had the following side effects: hyperkalaemia, hypokalaemia, rebound effect. Pentothal dosage: See Image. During the same period patient was treated with SODIUM CHLORIDE 3% (SODIUM CHLORIDE) (View Sodium Chloride 3% (sodium Chloride) Review and Sodium Chloride 3% (sodium Chloride) Label ), MANNITOL 20% (MANNITOL) (View Mannitol 20% (mannitol) Review and Mannitol 20% (mannitol) Label ), PROPOFOL (View Propofol Review and Propofol Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ), NOREPINEPHRINE BITARTRATE (View Norepinephrine Bitartrate Review and Norepinephrine Bitartrate Label ), VASOPRESSIN (VASOPRESSIN) (View Vasopressin (vasopressin) Review and Vasopressin (vasopressin) Label ).

5723581-4 | Cardiac Arrest, Hyperkalaemia, Hypokalaemia, Rebound Effect
on Apr 15, 2008 Male patient from CANADA , 53 years of age, was diagnosed with intracranial pressure increased and was treated with Pentothal (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), hyperkalaemia, hypokalaemia, rebound effect. Pentothal dosage: 5 Mg/kg, Once, Intravenous Bolus; 3.75 Mg/kg/hr, Infusion. During the same period patient was treated with SODIUM CHLORIDE 3% (SODIUM CHLORIDE) (View Sodium Chloride 3% (sodium Chloride) Review and Sodium Chloride 3% (sodium Chloride) Label ), MANNITOL 20% (MANNITOL) (View Mannitol 20% (mannitol) Review and Mannitol 20% (mannitol) Label ), PROPOFOL (View Propofol Review and Propofol Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ), NOREPINEPHRINE BITARTRATE (View Norepinephrine Bitartrate Review and Norepinephrine Bitartrate Label ), ANTIBIOTIC (ANTIBIOTICS) (View Antibiotic (antibiotics) Review and Antibiotic (antibiotics) Label ), INSULIN (INSULIN) (View Insulin (insulin) Review and Insulin (insulin) Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ).

5723555-3 | Hyperkalaemia, Hypokalaemia, Ventricular Tachycardia
Patient was taking Pentothal (View Usage). Patient had the following side effects: hyperkalaemia, hypokalaemia, ventricular tachycardia on Apr 15, 2008 from CANADA Additional patient health information: Female patient , 24 years of age, was diagnosed with intracranial pressure increased and. Pentothal dosage: 3 Mg/kg, Once, Intravenous Bolus; 5 Mg/kg/hr, Continuous Infusion; 3 Mg/kg/hr, Continuous Infusion. During the same period patient was treated with SODIUM CHLORIDE 3% (SODIUM CHLORIDE) (View Sodium Chloride 3% (sodium Chloride) Review and Sodium Chloride 3% (sodium Chloride) Label ), MANNITOL 20% (MANNITOL) (View Mannitol 20% (mannitol) Review and Mannitol 20% (mannitol) Label ), PROPOFOL (View Propofol Review and Propofol Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ), NOREPINEPHRINE BITARTRATE (View Norepinephrine Bitartrate Review and Norepinephrine Bitartrate Label ), VASOPRESSIN (VASOPRESSIN) (View Vasopressin (vasopressin) Review and Vasopressin (vasopressin) Label ), ANTIBIOTIC (ANTIBIOTICS) (View Antibiotic (antibiotics) Review and Antibiotic (antibiotics) Label ), MORPHINE (View Morphine Review and Morphine Label ).

5652075-X | Cardiac Arrest, Suicide Attempt
Adverse event was reported on Feb 25, 2008 by a Female patient taking Pentothal (View Usage) (Dosage: Intravenous) . Location: TURKEY , 35 years of age, After Pentothal was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), suicide attempt.

5586981-1 | Operative Haemorrhage, Parotid Gland Enlargement, Parotitis, Post Procedural Complication
on Dec 28, 2007 Female patient from TAIWAN, PROVINCE OF CHINA , 53 years of age, weighting 123.5 lb, was diagnosed with induction of anaesthesia, maintenance of anaesthesia and was treated with Pentothal (View Usage). Patient experienced the following unwanted or unexpected effects: operative haemorrhage, parotid gland enlargement, parotitis, post procedural complication. Pentothal dosage: 275 Mg, Intravenous. During the same period patient was treated with FENTANYL (150 Mcg,) (View Fentanyl Review and Fentanyl Label ), ROCURONIUM (ROCURONIUM) (50 Mg,) (View Rocuronium (rocuronium) Review and Rocuronium (rocuronium) Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ).

5586739-3 | Parotid Gland Enlargement, Procedural Pain
on Dec 28, 2007 Male patient from TAIWAN, PROVINCE OF CHINA , 52 years of age, weighting 165.3 lb, was diagnosed with induction of anaesthesia, maintenance of anaesthesia and was treated with Pentothal (View Usage). Patient had the following side effects: parotid gland enlargement, procedural pain. Pentothal dosage: 275 Mg, Intravenous. During the same period patient was treated with FENTANYL (150 Mcg,) (View Fentanyl Review and Fentanyl Label ), ROCURONIUM (ROCURONIUM) (50 Mg,) (View Rocuronium (rocuronium) Review and Rocuronium (rocuronium) Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ).

5416528-1 | Anaesthetic Complication, Anaphylactic Reaction, Pulse Absent
Patient was taking Pentothal (View Usage). After Pentothal was administered, patient had the following side effects: anaesthetic complication, anaphylactic reaction, pulse absent on Aug 03, 2007 from ITALY Additional patient health information: Female patient , 14 years of age, . Pentothal dosage: 300 Mg, Once, Intravenous. During the same period patient was treated with ATRACURIUM BESYLATE (40 Mg, Once, Intravenous) (View Atracurium Besylate Review and Atracurium Besylate Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), EUTIROX (LEVOTHYROXINE) (View Eutirox (levothyroxine) Review and Eutirox (levothyroxine) Label ), OXYGEN (OXYGEN) (View Oxygen (oxygen) Review and Oxygen (oxygen) Label ).

5325390-7 | Neutropenia
Adverse event was reported on Apr 26, 2007 by a Female patient taking Pentothal (View Usage) (Dosage: See Image) was diagnosed with coma, pneumonia (What is pneumonia?), convulsion prophylaxis and. Location: CANADA , 29 years of age, weighting 165.0 lb, Patient experienced the following unwanted or unexpected effects: neutropenia. During the same period patient was treated with VANCOMYCIN (See Image) (View Vancomycin Review and Vancomycin Label ), PHENYTOIN (18 Mg/kg, Once, Intravenous) (View Phenytoin Review and Phenytoin Label ), PIPERACILLIN AND TAZOBACTAM (View Piperacillin And Tazobactam Review and Piperacillin And Tazobactam Label ), 20% MANNITOL (MANNITOL) (View 20% Mannitol (mannitol) Review and 20% Mannitol (mannitol) Label ), 3% HYPERTONIC SALINE INFUSION (SODIUM CHLORIDE) (View 3% Hypertonic Saline Infusion (sodium Chloride) Review and 3% Hypertonic Saline Infusion (sodium Chloride) Label ), ROCURONIUM (ROCURONIUM) (View Rocuronium (rocuronium) Review and Rocuronium (rocuronium) Label ), PROPOFOL (View Propofol Review and Propofol Label ), NOREPINEPHRINE BITARTRATE (View Norepinephrine Bitartrate Review and Norepinephrine Bitartrate Label ).

5325389-0 | Febrile Neutropenia, Infection, Intracranial Pressure Increased, No Therapeutic Response
on Apr 26, 2007 Male patient from CANADA , 26 years of age, weighting 179.0 lb, was diagnosed with coma, convulsion prophylaxis and was treated with Pentothal (View Usage). Patient had the following side effects: febrile neutropenia, infection (What is infection?), intracranial pressure increased, no therapeutic response. Pentothal dosage: See Image. During the same period patient was treated with PHENYTOIN (See Image) (View Phenytoin Review and Phenytoin Label ), PROPOFOL (View Propofol Review and Propofol Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), NOREPINEPHRINE BITARTRATE (View Norepinephrine Bitartrate Review and Norepinephrine Bitartrate Label ), INSULIN (INSULIN) (View Insulin (insulin) Review and Insulin (insulin) Label ), 20% MANNITOL (MANNITOL) (View 20% Mannitol (mannitol) Review and 20% Mannitol (mannitol) Label ), 3% SALINE (SODIUM CHLORIDE) (View 3% Saline (sodium Chloride) Review and 3% Saline (sodium Chloride) Label ), ROCURONIUM (ROCURONIUM) (View Rocuronium (rocuronium) Review and Rocuronium (rocuronium) Label ).

5290123-X | Hypotension
on Mar 20, 2007 Male patient from TAIWAN, PROVINCE OF CHINA , 76 years of age, weighting 134.5 lb, was diagnosed with induction of anaesthesia and was treated with Pentothal (View Usage). After Pentothal was administered, patient had the following side effects: hypotension. Pentothal dosage: 10 Ml, Not Reported, Epidural. During the same period patient was treated with PROPOFOL (0.4 Mg/kg/min, Not Reported, Intravenous Infusion) (View Propofol Review and Propofol Label ), LIDOCAINE 2% (LIDOCAINE) (View Lidocaine 2% (lidocaine) Review and Lidocaine 2% (lidocaine) Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), ROCURONIUM (ROCURONIUM) (View Rocuronium (rocuronium) Review and Rocuronium (rocuronium) Label ), DESFLURANE 6% IN 100% OXYGEN (View Desflurane 6% In 100% Oxygen Review and Desflurane 6% In 100% Oxygen Label ).

5097302-5 | Cerebral Haemorrhage, Cortical Laminar Necrosis, Haemodynamic Instability
Patient was taking Pentothal (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage, cortical laminar necrosis, haemodynamic instability on Aug 22, 2006 from BELGIUM Additional patient health information: Male patient , child 9 years of age, was diagnosed with status epilepticus and. Pentothal dosage: Up To 1 Mg/kg/hr, Infusion. During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ), PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), CHLORMETHIAZOLE (CLOMETHIAZOLE) (View Chlormethiazole (clomethiazole) Review and Chlormethiazole (clomethiazole) Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), VIGABATRIN (View Vigabatrin Review and Vigabatrin Label ).

4954500-6 | Pulmonary Oedema
Adverse event was reported on Mar 10, 2006 by a Male patient taking Pentothal (View Usage) (Dosage: See Image) was diagnosed with epilepsy (What is epilepsy?) and. Location: FRANCE , weighting 165.3 lb, Patient had the following side effects: pulmonary oedema. During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), CLAVULANIC ACID (CLAVULANIC ACID) (View Clavulanic Acid (clavulanic Acid) Review and Clavulanic Acid (clavulanic Acid) Label ). Patient was hospitalized.

4948069-X | Agranulocytosis, Blister, Cytolytic Hepatitis, Neutropenia, Pyrexia, Rash
on Feb 23, 2006 Male patient from FRANCE , 23 years of age, was treated with Pentothal (View Usage). After Pentothal was administered, patient had the following side effects: agranulocytosis, blister, cytolytic hepatitis, neutropenia, pyrexia, rash (What is rash?). Pentothal dosage: . During the same period patient was treated with ACETAMINOPHEN (Per Oral) (View Acetaminophen Review and Acetaminophen Label ), PHENOBARBITAL TAB (Per Oral) (View Phenobarbital Tab Review and Phenobarbital Tab Label ), ENOXAPARIN SODIUM (Subcutaneous) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ). Patient was hospitalized.

4865066-3 | Bronchospasm, Hypotension, Rash Papular
on Dec 07, 2005 Female patient from FRANCE , 53 years of age, was diagnosed with anaesthesia and was treated with Pentothal (View Usage). Patient experienced the following unwanted or unexpected effects: bronchospasm, hypotension, rash papular. Pentothal dosage: Intravenous. During the same period patient was treated with SUFENTANIL (SUFENTANIL) (Intravenous) (View Sufentanil (sufentanil) Review and Sufentanil (sufentanil) Label ). Patient was hospitalized.

4840070-X | Apallic Syndrome, Dementia, Faecal Incontinence, Movement Disorder, Speech Disorder, Urinary Incontinence
Patient was taking Pentothal (View Usage). Patient had the following side effects: apallic syndrome, dementia (What is dementia?), faecal incontinence, movement disorder (What is movement disorder?), speech disorder, urinary incontinence (What is urinary incontinence?) on Nov 11, 2005 from UNITED KINGDOM Additional patient health information: Male patient , 73 years of age, was diagnosed with induction of anaesthesia and. Pentothal dosage: . During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), OMNOPON (OPIUM ALKALOIDS TOTAL) (View Omnopon (opium Alkaloids Total) Review and Omnopon (opium Alkaloids Total) Label ), HYOSCINE HBR HYT (View Hyoscine Hbr Hyt Review and Hyoscine Hbr Hyt Label ), ATROPINE (View Atropine Review and Atropine Label ), TRICHLOROETHYLENE (TRICHLOROETHYLENE) (View Trichloroethylene (trichloroethylene) Review and Trichloroethylene (trichloroethylene) Label ), OXYGEN (OXYGEN) (View Oxygen (oxygen) Review and Oxygen (oxygen) Label ).

4781645-6 | Resuscitation, Ventricular Fibrillation
Adverse event was reported on Sep 16, 2005 by a Female patient taking Pentothal (View Usage) (Dosage: Intravenous) . Location: PAKISTAN , 25 years of age, weighting 99.21 lb, After Pentothal was administered, patient had the following side effects: resuscitation, ventricular fibrillation. During the same period patient was treated with ISONIAZID (View Isoniazid Review and Isoniazid Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), ETHAMBUTOL (ETHAMBUTOL) (View Ethambutol (ethambutol) Review and Ethambutol (ethambutol) Label ), PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), ATRACURIUM BESYLATE (View Atracurium Besylate Review and Atracurium Besylate Label ).

4751251-8 | Blood Potassium Increased, Bradycardia, Brain Oedema, Cardiac Arrest, Computerised Tomogram Abnormal, Condition Aggravated, Hypokalaemia
on Aug 11, 2005 Female patient from KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF , 21 years of age, was diagnosed with intracranial pressure increased and was treated with Pentothal (View Usage). Patient experienced the following unwanted or unexpected effects: blood potassium increased, bradycardia, brain oedema, cardiac arrest (What is cardiac arrest?), computerised tomogram abnormal, condition aggravated, hypokalaemia. Pentothal dosage: 5 Mg/kg, Intravenous : 5 Mg/kg, Per Hour, Continuous Infusion.

4736507-7 | Blood Pressure Increased
on Jul 22, 2005 Female patient from CANADA , 41 years of age, was treated with Pentothal (View Usage). Patient had the following side effects: blood pressure increased. Pentothal dosage: 500 Mg, Over 3 Doses,. During the same period patient was treated with SUCCINYCHOLINE (S UXAMETHONIUM CHLORIDE) (View Succinycholine (s-uxamethonium Chloride) Review and Succinycholine (s-uxamethonium Chloride) Label ).

4665033-9 | Cardiac Arrest, Fluid Retention, Haemodialysis, Haemodynamic Instability, Hyperkalaemia, Hypokalaemia, Post Procedural Complication, Tachycardia, Uterine Enlargement
Patient was taking Pentothal (View Usage). After Pentothal was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), fluid retention, haemodialysis, haemodynamic instability, hyperkalaemia, hypokalaemia, post procedural complication, tachycardia, uterine enlargement on May 09, 2005 from Additional patient health information: Female patient , 35 years of age, was diagnosed with sedation and. Pentothal dosage: 2-3mg.kg-1, Intravenous. During the same period patient was treated with MIDAZOLAM (View Midazolam Review and Midazolam Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), NIMBEX (View Nimbex Review and Nimbex Label ).

4644812-8 | Agranulocytosis, Pyrexia
Adverse event was reported on Apr 15, 2005 by a Female patient taking Pentothal (View Usage) (Dosage: Intravenous) . Location: , 20 years of age, Patient experienced the following unwanted or unexpected effects: agranulocytosis, pyrexia. Patient was hospitalized.

4620997-4 | Atrial Fibrillation, Bradycardia, Cardiac Arrest, Post Procedural Nausea, Torsade De Pointes, Ventricular Hypokinesia
on Mar 18, 2005 Male patient from , 36 years of age, weighting 176.4 lb, was diagnosed with induction of anaesthesia, maintenance of anaesthesia, post procedural nausea and was treated with Pentothal (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), bradycardia, cardiac arrest (What is cardiac arrest?), post procedural nausea, torsade de pointes, ventricular hypokinesia. Pentothal dosage: 500 Mg, Intravenous. During the same period patient was treated with SUXAMETHONIUM (100 Mg, Intravenous) (View Suxamethonium Review and Suxamethonium Label ), DESFLURANE (Inhalation) (View Desflurane Review and Desflurane Label ), SUFENTANIL CITRATE (60, ^last Iv Flush At 11:00 Pm^, Intravenous) (View Sufentanil Citrate Review and Sufentanil Citrate Label ), ROPIVACAINE (7.5 Milligram/milliliters, 15 Ml, Not Reported) (View Ropivacaine Review and Ropivacaine Label ), ONDANSETRON (Intravenous) (View Ondansetron Review and Ondansetron Label ).

4553284-3 | Cardiac Arrest, Coma
on Dec 31, 2004 Female patient from , child 8 years of age, was treated with Pentothal (View Usage). After Pentothal was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), coma. Pentothal dosage: Intravenous.